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Abstract
Ethylcellulose/methylcellulose blends were produced using different precipitation techniques and impregnated with naproxen, a non-steroidal
anti-inflammatory drug (NSAID). Solvent-evaporation technique was used not only for the preparation of ethylcellulose/methylcellulose micro-
spheres but also to encapsulate naproxen. Supercritical fluid (SCF) impregnation was also performed to prepare naproxen loaded microspheres. The
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dicrospheres, impregnated by the SCF technique, were prepared both by solvent-evaporation and by a supercritical antisolvent (SAS) process. In
itro release profiles at pH 7.4 and 1.2, of naproxen-loaded microspheres were evaluated and the results were modelled Fick’s law of diffusion and
ower law. Miscrospheres prepared by supercritical antisolvent have a higher loading capacity and present a slower release profile. The systems
tudied present a release mechanism controlled by drug diffusion which complies Fick’s law of diffusion.
2005 Elsevier B.V. All rights reserved.
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. Introduction
Controlled drug delivery products, using biocompatible or
iodegradable polymers, have received considerable attention
n the last years. These substances provide in general a more
ontrolled rate of assumption of the drug by the body improving
ts therapeutic action. In fact, there is a growing interest of the
harmaceutical industry in the development of these systems
Heller, 1996).
In many cases, conventional drug delivery products provide
harp increases in the drug concentration at potentially toxic
evels, followed by a relatively short period at the therapeu-
ic level and drug concentration drops until new administration
Freiberg and Zhu, 2004). Controlled drug delivery occurs when
polymer/drug system is designed to release the drug in a prede-
ermined manner. The main purpose of these controlled release
ystems is to achieve a more effective therapy, i.e., a system with
delivery profile that would yield a high blood level of the drug
∗ Corresponding author.
over a long period of time, avoiding the large fluctuations in drug
concentration and to reduce the need of several administrations
(Lisa Brannon-Peppas, 1997).
The preparation of drug release products necessitates the use
of a mobile phase to dissolve and carry the drug component,
which also swells and stretches the polymer matrix, facilitating
the diffusion of the drug, and increasing the rate of impregna-
tion. Conventionally, the preparation of these systems involves
three steps: solubilization of the pharmaceutical in an appropri-
ate solvent, diffusion of the pharmaceutical through the polymer
and elimination of the residual solvent.
Impregnation using supercritical fluid technology has proven
to be feasible when the pharmaceutical compound is solu-
ble in carbon dioxide and the polymer can be swollen by the
supercritical fluid. A high purity product, free of residual sol-
vents is obtained, since no organic solvents are involved in the
impregnation process (Kikic and Vecchione, 2003; Elvira et al.,
2004). Supercritical fluids, especially supercritical carbon diox-
ide (scCO2) have been identified as prime candidates to develop
alternative clean processes for the preparation of drug-loaded
polymeric matrixes (Kikic and Sist, 2000). Furthermore, the useE-mail address: rduarte@itqb.unl.pt (A.R.C. Duarte). of supercritical fluids can take advantage of their high diffu-
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sivity in polymers, in combination with the high solubility and
plasticizing action. Therefore, compressed CO2 is considered a
good drug carrier into biocompatible polymers. Moreover, when
depressurisation occurs, the gas rapidly diffuses out of the poly-
mer, deplasticizing it and warranting the complete removal of
solvent, without exposing polymers and drugs to high tempera-
tures, which may degrade them (Berens et al., 1992; Kazarian,
2004).
Polymer nanosuspensions of non-steroidal anti-inflam-
matory (NSAIDs) agents have been proposed as controlled
delivery systems able to solve pharmacokinetic problems and
some typical side effects of most of these drugs, namely, gas-
trointestinal adverse side-effects. The preparation of controlled
release systems for these pharmaceutical compounds is the lead-
ing way to overcome this problem.
Although many polymers are used in the pharmaceuti-
cal industry, cellulose derivatives are among the most com-
monly used (Rekhi and Jambhekar, 1995). Ethylcellulose is a
hydrophobic material used in a variety of applications such as
sustained release and taste masking. It has been widely used to
prepare controlled delivery systems of water-soluble materials.
The drug release can be controlled to some extend by addition of
a water-soluble or water swellable polymer, as methylcellulose
(Handbook of Pharmaceutical Excipients, in press).
Being the most part of NSAIDs lipophilic drugs, the solvent
evaporation method is generally used for their microencapsula-
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Pereira. Carbon dioxide (99.998 mol%) was supplied by Air Liq-
uide. All chemicals were used with no further purification.
2.1.1. Preparation of microspheres
2.1.1.1. Solvent-evaporation technique. Drug-free and micro-
particles containing naproxen were prepared by the solvent
evaporation method. 2 g of ethylcellulose were dissolved in
20 ml of the organic solvent (dichloromethane, in some cases
containing 5 or 10 ml of acetone). When preparing naproxen-
loaded microparticles, 1.2 g of drug was added to this solution.
The solution of organic phase was slowly poured into 250 ml of
a 2.5% w/v (in some cases 5% w/v or 7.5% w/v) methylcellulose
aqueous solution, which acts as an emulsifying agent, and stirred
with a two-baffled rotator for 1 h at a controlled stirring speed of
800 rpm. The formed oil-in-water (o/w) emulsion was then gen-
tly stirred at room temperature until complete evaporation of the
solvent. Microparticles were then collected by centrifugation at
10 000 rpm for 20 min (B. Braun, model Sigma 4K10), washed 4
times with distilled water, filtered (Millipore, pore size 0.45m)
and dried in a desiccator under vacuum at room temperature.
2.1.1.2. Supercritical antisolvent (SAS) technique. A solu-
tion of ethylcellulose + methylcellulose was prepared in
DCM + DMSO to be injected in a SAS apparatus. In order to
change the porosity of the polymeric matrix a water-soluble sol-
vent, acetone, was added to the solution. The apparatus works in
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aion. However, during the microencapsulation process, a partial
rystallization of the free drug can take place, which is unde-
irable since its release is not going to be controlled by the
olymeric matrix (Leo et al., 2000).
In this work, in vitro release profiles of naproxen-loaded
icrospheres prepared by different techniques were investi-
ated. Solvent-evaporation technique was used to produce not
nly ethylcellulose/methylcellulose microspheres but also to
ncapsulate naproxen. Supercritical fluid impregnation was per-
ormed to prepare controlled release naproxen microspheres.
he microspheres were prepared both by solvent-evaporation
nd by supercritical antisolvent process (SAS). The SAS pro-
ess is the supercritical precipitation process most commonly
sed, since non-soluble solutes in carbon dioxide can be pro-
essed. This is also the technique focused in this work. The
rinciple of this process is to decrease the solvent power of
he liquid by addition of an antisolvent (CO2) in which the
olute is insoluble (Jung and Perrut, 2001; Reverchon et al.,
001).
. Experimental procedure
.1. Materials
Ethylcellulose (48.0–49.5% w/w ethoxyl content) (CAS
004-57-3) Methylcellulose, with an intrinsic viscosity
160 mPa s (CAS 9004-67-5) were purchased from Fluka.
aproxen (CAS 22204-53-1, 98.0% purity) was purchased from
igma. Dichloromethane, DCM (CAS 78-09-2, 99.9% purity),
imethylsulphoxide, DMSO (CAS 67-68-5, 99.9% purity) and
cetone (CAS 67-64-1, 99.5% purity) were purchased from Vazcontinuous co-current mode and it consists in a precipitator in
hich the antisolvent and the liquid solution are separately fed
o the top of the chamber and are continuously discharged from
he bottom (Fig. 1). The liquid solution is delivered into the pre-
ipitation chamber through a stainless steel nozzle (100m). A
lter of sintered steel with 0.1m porosity is placed at the bot-
om of the vessel to collect the particles produced. The solvents
re separated and recovered from a second vessel. Usually the
emperature of the vessel is around 15 ◦C and pressure 5–10 bar.
he experiments were carried out all at the same operational
onditions (80 bar, 35 ◦C, CO2 flow 8.5 L/min, 1 mL/min).
.1.2. Supercritical impregnation process
The impregnation is performed in a semi-continuous appara-
us described schematically in Fig. 2.
A tubular batch extraction cell is initially loaded with the
harmaceutical compound and packed between a sequence of
filter paper, cotton and net metallic discs that work as filters
f small particles. The polymer is loaded, in the same man-
er, in the impregnation cell. The cells are then immersed in
thermostatized water bath heated by means of a controller
hat maintains temperature within ±0.1 ◦C (TC) (Ero Electronic
MS-491-13). Carbon dioxide is pumped into the cells using
igh pressure piston pump (Haskel model MCPV-71) until the
perational pressure is attained. In the intervening time the cells
re not connected to each other, however they are at the exact
ame pressure. The pressure inside the cells is measured with a
ressure transducer (P) (LEO2 0.300 bar). The solubilization of
he drug in the supercritical fluid and the swelling of the polymer
ue to the presence of carbon dioxide take place during one hour,
typical equilibrium time. Preliminary experiments with other
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Fig. 1. SAS apparatus (TIC, temperature transducer; TI, temperature indicator;
P, pressure transducer; BPR, back pressure regulator; FM, flow meter; PpV,
precipitation vessel; SRV, solvent recuperation vessel).
contact times were performed and similarly to other polymers
and common model drugs, 1 h was found to be the adequate
contact time for both the swelling of the polymeric matrix and
solubilisation of the drug in scCO2. Opening valve V1 the cells
are placed in contact and the continuous process of impregna-
tion starts. A saturated stream of the pharmaceutical compound
in carbon dioxide passes through the polymeric matrix, for a
predetermined period of time and at a very slow rate so that the
impregnation can occur. The outflow is regulated by a metering
valve (Hoke 1315G4Y), in order to maintain a constant pressure
in the system and a slow carbon dioxide flow, which is mea-
sured with a flowmeter (FM) (Alexander Wright DM3C). The
solid that might be solubilized in the gas is collected in a small
glass trap (T). The impregnation time for all the experiments
presented was 2 h 30 min. At the end of this period the system is
quickly depressurized and the impregnated sample is collected
from the impregnation cell.
2.1.3. Microspheres characterization
2.1.3.1. Scanning electron microscopy (SEM). Samples of the
precipitated powder were observed by a ZAISS 960 scanning
electron microscope (SEM). The particles were fixed by mutual
conductive adhesive tape on aluminium stubs and covered with
gold palladium using a sputter coater.
2.1.3.2. In vitro drug release studies. Drug impregnated micro-
spheres (20 mg) were suspended in 40 ml of phosphate buffer
solution (pH 7.4) and simulated gastric fluid without pepsin
(pH 1.2) stirred at 150 rpm at 37 ◦C. A 0.5 ml aliquots were
withdrawn at predetermined time intervals and the same vol-
ume of fresh medium was added to the suspension. The sam-
ples were filtered (0.45m, Millipore filters) and analysed
by HPLC (ThermoFinnigan Surveyor consisting of a quater-
nary pump, autosampler and diode array detector). A C18
column (Merck Lichrospher 250-4, 5m) kept at 30 ◦C, was
used in isocratic conditions with a mobile phase consisting of
water:acetonitrile:acetic acid (500:490:10). The flow rate was
1.2 ml/min and the volume of injection was 20l. Quantitation
was performed at 280 nm by external standard calibration.
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aFig. 2. Schematic representation of the impregnation apparatus.The total mass of released drug in each moment of the exper-
ment was calculated taking into account the aliquots taken and
he dilution produced by addition of fresh buffer.
. Mathematical modelling of drug release
The knowledge of the mass transport mechanisms and the
inetics of the drug release are essential for the design of new
rug delivery systems. Several models from simple empirical
r semi-empirical to more complex mechanistic theories have
een proposed to describe drug release from delivery systems
Higuchi, 1961; Siempmann and Peppas, 2001).
A proportionality between the fractional amount of drug
eleased and the square root of time can as well be described
y an exact solution of Fick’s law of diffusion (Crank, 1975,
968):
Mt
M∞
= 4
(
Dt
π2
)1/2
= k′√t, (1)
here l is the thickness of the system and k′ is the kinetic con-
tant. The linearity of this equation can only be verified up to
0% of the total amount of drug (M∞).
Another case is one where the drug release rate is indepen-
ent of time, i.e., it corresponds to a zero-order kinetics. Many
ituations of release processes fall between these cases, the Fick-
an diffusion and the zero-order kinetics. An heuristic equation,
nown as power law, that translates this behaviour can be written
s (Ritger and Peppas, 1987a, 1987b):
Mt
M∞
= ktn, (2)
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where k is a constant and n is the diffusional exponent,
which is indicative of the transport mechanism. Like Eq. (1)
this relationship is only valid for the first 60% of the drug
released.
4. Results
Microspheres of ethylcellulose/methylcellulose were pre-
pared by solvent-evaporation technique and using a supercritical
antisolvent process. Particles produced using supercritical tech-
nology present a small diameter and a narrower size distribution
(Fig. 3).
Comparing the particle size distribution of the pure ethylcel-
lulose with one of the blends micronized by SAS there is a greater
polydispersity, which is due to the fact that in the later case we
two polymers are being co-precipitated. Nevertheless, the super-
critical antisolvent process still presents enormous advantages
when comparing with conventional techniques such as solvent
evaporation. Table 1 presents the characteristics of the particles
produced.
The release profiles of the different systems prepared were
performed. For the same polymeric blend is clear that the tech-
niques used to both prepare and impregnate the microspheres
influence the percentage of impregnated drug. Fig. 4 illustrates
the release profile in terms of drug concentration. The trend of
the curves are different suggesting that they present different
kinetics, therefore different release rates.
The release behaviour presented is similar for each blend
impregnated. The process technique used to prepare the deliv-
ery system is clearly a factor that influences the release rates.
The release rates are higher when the microspheres were
prepared using the solvent-evaporation technique and lower
in the case that particles were prepared by the conventional
technique and impregnated with CO2. Particles prepared by
solvent-evaporation and impregnated using supercritical fluid
technology present a very slow release profile, only 40% ofFig. 3. SEM images and particle size distribution of the particles prepared.
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Table 1
Characteristics of the particles prepared
System Method of preparation Method of impregnation MSD (m) w/v % methylcellulose % impregnationb
1 Ethyl/methyl Solv-evap Solv-evap 126.7 0.25 57.7
2 Ethyl/methyl Solv-evap Solv-evap 225.7 0.5 63.3
3 Ethyl/methyl Solv-evap Solv-evap 149.5 0.75 76.3
4 Ethyl/methyl Solv-evap Solv-evap 200.9 0.25a 63.5
5 Ethyl/methyl Solv-evap Solv-evap 130.6 0.25a 65.2
6 Ethyl/methyl Solv-evap SCF impregnation 126.7 0.25 1
7 Ethyl/methyl Solv-evap SCF impregnation 225.7 0.5 2.2
8 Ethyl/methyl Solv-evap SCF impregnation 149.5 0.75 1.7
9 Ethyl/methyl Solv-evap SCF impregnation 200.9 0.25a 1.6
10 Ethyl/methyl Solv-evap SCF impregnation 130.6 0.25a 0.9
11 Ethyl/methyl SAS SCF impregnation 16.91 0.25 4.1
12 Ethyl/methyl SAS SCF impregnation 17.65 0.5 3.2
13 Ethyl/methyl SAS SCF impregnation 23.12 0.25a 2.1
14 Ethylcellulose SAS SCF impregnation 4.71 – 3.2
a Particles prepared in the presence of acetone (4, 9, 13 with 25% and 5, 10 with 50%).
b Relative quantity of drug in an impregnated sample, expressed in w/w percentage.
Fig. 4. Release profiles (pH 7.4) of the systems prepared with 0.25% (w/v) methylcellulose by () solv-evap + sc impregnation; (*) SAS + sc impregnation; (♦)
solv-evap.
the drug is released after 8–10 h. Considering that these micro-
spheres were prepared for oral medication and since the gas-
trointestinal transit time is considered to be 6–8 h, as reported
by Davis (1985), the particles prepared using solvent evapo-
ration or supercritical fluid technology seem to be the most
promising ones. Nonetheless, the conventional method for the
preparation of the microspheres presents the drawbacks already
pointed out. So, supercritical fluid technology presented very
promising results in the preparation of new drug delivery
systems.
Regarding the different formulations, interesting results were
obtained. The formulation process has a much greater impact
on the release profile when supercritical fluids are used in
the impregnation step. Fig. 5(a) and (b) represent respectively
the release profiles of the different formulations prepared with
the conventional technique of solvent-evaporation and when
microspheres prepared conventionally were impregnated using
CO2. When naproxen-loaded particles were prepared by solvent-
evaporation the release rates are similar as the initial slope of the
release profile curve is similar. However, when the particles were
Fig. 5. Release profiles (pH 7.4) of the systems prepared by (a) solvent-evaporation technique and (b) solv-evap + sc impregnation with (*) 0.25% (w/v), () 0.5%
(w/v), (♦) 0.75 (%w/t) methylcellulose.
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Fig. 6. Release profiles (pH,7.4) of the systems prepared in the presence of 0% (open symbols) and 25% acetone (filled symbols): (♦) and () solvent-evaporation
technique; (©) and () solv-evap + sc impregnation; () and () SAS + sc impregnation with 0.25% (w/v) methylcellulose.
prepared by solvent evaporation and then impregnated using
supercritical fluid technology the trends of the curves are dif-
ferent leading to different initial slopes, and therefore different
release kinetics.
The presence of acetone in the preparation of the micro-
spheres does not affect the kinetics of the release and the drug
release rate is the same as the initial slopes are also the same
(Fig. 6). The release profiles of the samples were also evalu-
ated at two different pHs 1.2 and 7.4, simulating respectively
the gastric and intestinal environment (Fig. 7). All the formu-
lations prepared and impregnated by solvent evaporation and
the ones prepared by SAS and impregnated using supercritical
fluids present an almost insignificant release rate in acidic solu-
tion, meaning that the release would mainly occur in the intes-
tine. This is due to the fact that there is a higher drug release
rate in these systems. When particles were produced by solvent
evaporation and then were impregnated using supercritical flu-
ids the difference is not significant since only a low percentage
of drug is released.
To better understand the drug release mechanism of the sys-
tem prepared, Fick’s law of diffusion and Power law have been
applied. Fick’s law fitted well the data up to 60% of release for
all experiments.
The power law is another simple semi-empirical equation that
was applied to the results obtained. Although there is a very good
correlation between the percentage of drug released and the time
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Fig. 8. Release profile of the system prepared by solvent-evaporation (0.25%
(w/v) methylcellulose): () experimental data; (—) Fick’s law of diffusion.
(Ritger and Peppas, 1987), that was the case when particles were
prepared by SAS. In this case, the exponent values obtained
when Power law was applied to experimental data, were found
to be in the range of 0.43–0.85, meaning that the release was an
anomalous Fickian behaviour (Fig. 8).
In Table 2, the kinetic constants determined based on the
Fickian model, for experiments 1, 6 and 11 are presented.
When the same technique was used to prepare and impreg-
nate the particles, the kinetics constants were similar, namely
particles prepared and impregnated by solvent evaporation and
particles prepared by SAS and impregnated using supercritical
fluid technology. These kinetic constants were higher than in the
case when particles were prepared by solvent-evaporation and
impregnated using supercritical fluid technology. In this case,
the impregnated particles present a considerably large diameter.
This, combined with the fact that the drug carried by the super-
critical fluid, during the impregnation process, is entrapped in
the core of the particle (due to the high diffusivity of carbon
dioxide through the polymer matrix) and the longer diffusion
path, leads to a slower release of the drug.
Table 2
Kinetic constant calculated from Fick’s model, for the impregnation experiments
with the system 0.25% w/v methylcellulose
Experiment k1
1f release, the release exponent obtained did not always fit the
alues established for the case of a spherical sample (Siempmann
nd Peppas, 2001). Peppas et al. have studied the effect of the
article size distribution on the calculated diffusional exponent
nd have come to the conclusion that the “limits” set for spherical
amples can only be applied if the particles are monodisperse
ig. 7. Release profiles of the system prepared using the SAS + sc fluid impreg-
ation (0.25% (w/v) methylcellulose (25% acetone)): (♦) pH 7.4; () pH 1.2.1 0.6
6 0.1
1 0.5
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5. Conclusions
Supercritical fluid technology for the preparation of
naproxen-loaded ethylcellulose/methylcellulose microspheres
for controlled-release systems has proven to have significant
advantages comparing with the solvent evaporation technique.
The supercritical antisolvent (SAS) process presented enor-
mous advantages for the preparation of the polymeric micropar-
ticles when comparing with conventional technique, as the par-
ticles prepared have a smaller size diameter and a narrower
particle size distribution.
The process technique used to prepare the delivery system is
clearly a factor that influences the percentage of drug impreg-
nated in the polymer microspheres. The particles prepared by
solvent evaporation and impregnated using supercritical fluid
technology presented a slower release profile and only 40%
of the drug was released after 8–10 h. Microparticles prepared
and impregnated using the same technique showed a controlled
release profile and almost all the drug was released during what
is considered to be the gastrointestinal transit time. These obser-
vations are supported by the kinetic constants calculated when
Fickian diffusion model was applied to the experimental data.
Also, the microspheres prepared in the presence of acetone have
a slower release profile and this effect is more pronounced when
supercritical fluid technology was used to impregnate the drug
in the polymer.
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